Previous Close | 71.61 |
Open | 71.15 |
Bid | 69.64 x 900 |
Ask | 69.72 x 900 |
Day's Range | 69.21 - 71.26 |
52 Week Range | 61.28 - 101.24 |
Volume | |
Avg. Volume | 770,729 |
Market Cap | 6.114B |
Beta (5Y Monthly) | 1.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -4.28 |
Earnings Date | Aug 02, 2022 - Aug 08, 2022 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 118.33 |
Subscribe to Yahoo Finance Plus to view Fair Value for SRPT
Cell and gene therapy researchers and companies in Ohio attract buzz, but a panel of experts said the industry needs to do better at promoting a statewide brand to attract talent.
Bayer (BAYRY) beats estimates for both earnings and revenues in the first quarter of 2022.
Quite a few insiders have dramatically grown their holdings in Sarepta Therapeutics, Inc. ( NASDAQ:SRPT ) over the past...